W. L. Gore & Associates, Inc. (Gore) announced the launch of a new clinical quality improvement project on the newly FDA cleared hernia repair device, GORE® SYNECOR Biomaterial.

W. L. Gore & Associates has been active in the fuel cell industry since the 70s. Now Gore is providing a key component for the groundbreaking Toyota Mirai fuel cell vehicle.

W. L. Gore & Associates, Inc. (Gore) announced the Food and Drug Administration (FDA) approval of the GORE® EXCLUDER® Iliac Branch Endoprosthesis (IBE), making it the first off-the-shelf aortic branch device approved in the United States and the only device indicated for the endovascular treatment of common iliac artery aneurysms or aortoiliac aneurysms.

Gore earned the No. 12 spot on the 2016 Fortune 100 Best Companies to Work For® list, announced today.

W. L. Gore & Associates, Inc. (Gore) announced the availability of a new 7.5 centimeter length of the GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface.

W. L. Gore & Associates, Inc. (Gore) announced that more than 250,000 patients have been treated with the GORE® EXCLUDER® AAA Endoprosthesis.

W. L. Gore & Associates, Inc. (Gore) has introduced a new line of protective fabrics that deliver the best combination of broad protection, comfort, and durability for arc-flash rated, foul-weather protection.

W. L. Gore & Associates, Inc. (Gore) announced the first implant in the United States of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in a clinical study for the treatment of aortic aneurysms involving the visceral branch vessels.

W. L. Gore & Associates, Inc. has received a Supplier Appreciation Award from Space Systems Loral (SSL) Palo Alto, CA, the leading provider of geostationary commercial satellites, in recognition of Gore’s dedication in supporting SSL programs.

W. L. Gore & Associates announces the launch of the GORE® Acoustic Vent GAW333 – a small, smart way to improve handset acoustics while maintaining IPX8 immersion protection and IP6X particle protection.